
Tanisha Diggs
Examiner (ID: 4064, Phone: (571)270-7730 , Office: P/1761 )
| Most Active Art Unit | 1761 |
| Art Unit(s) | 1796, 1761 |
| Total Applications | 841 |
| Issued Applications | 423 |
| Pending Applications | 82 |
| Abandoned Applications | 357 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18148900
[patent_doc_number] => 20230022757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => MODIFIED VACCINIA VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/694115
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/694115 | MODIFIED VACCINIA VECTORS | Mar 13, 2022 | Abandoned |
Array
(
[id] => 19863716
[patent_doc_number] => 20250102502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => MULTIPLY LABELLED POLYMERIC CONSTRUCTS FOR DETECTION ASSAYS
[patent_app_type] => utility
[patent_app_number] => 18/280923
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280923
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280923 | MULTIPLY LABELLED POLYMERIC CONSTRUCTS FOR DETECTION ASSAYS | Mar 9, 2022 | Pending |
Array
(
[id] => 19433022
[patent_doc_number] => 20240301520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => METHOD FOR DETECTION OF SARS-CoV-2 MUTATIONS
[patent_app_type] => utility
[patent_app_number] => 18/277020
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277020
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277020 | METHOD FOR DETECTION OF SARS-CoV-2 MUTATIONS | Mar 6, 2022 | Pending |
Array
(
[id] => 17881224
[patent_doc_number] => 20220296701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => SYNTHETIC PLASMID DNA VACCINE EXPRESSING A CODON-OPTIMIZED SARS-COV-2 SPIKE PROTEIN AND METHODS FOR ITS USE
[patent_app_type] => utility
[patent_app_number] => 17/672045
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672045 | SYNTHETIC PLASMID DNA VACCINE EXPRESSING A CODON-OPTIMIZED SARS-COV-2 SPIKE PROTEIN AND METHODS FOR ITS USE | Feb 14, 2022 | Abandoned |
Array
(
[id] => 17735077
[patent_doc_number] => 20220220536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => COMPOSITIONS AND METHODS OF USING A DNA NANOSWITCH FOR THE DETECTION OF RNA
[patent_app_type] => utility
[patent_app_number] => 17/573529
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573529
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573529 | COMPOSITIONS AND METHODS OF USING A DNA NANOSWITCH FOR THE DETECTION OF RNA | Jan 10, 2022 | Pending |
Array
(
[id] => 17563160
[patent_doc_number] => 20220127309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => CHIMERIC MOLECULES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/573616
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573616 | Chimeric molecules and uses thereof | Jan 10, 2022 | Issued |
Array
(
[id] => 17561765
[patent_doc_number] => 20220125914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => CORONAVIRUS VACCINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/572182
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572182
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572182 | Corona virus vaccine formulations | Jan 9, 2022 | Issued |
Array
(
[id] => 19291582
[patent_doc_number] => 12030928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Anti-influenza B virus neuraminidase antibodies and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/569253
[patent_app_country] => US
[patent_app_date] => 2022-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 69
[patent_no_of_words] => 100163
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17569253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/569253 | Anti-influenza B virus neuraminidase antibodies and uses thereof | Jan 4, 2022 | Issued |
Array
(
[id] => 17685843
[patent_doc_number] => 20220193135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => MODIFIED IMMUNE EFFECTOR CELL AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/563804
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17563804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/563804 | MODIFIED IMMUNE EFFECTOR CELL AND PREPARATION METHOD THEREFOR | Dec 27, 2021 | Pending |
Array
(
[id] => 19034510
[patent_doc_number] => 20240084325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => BOVINE HERPESVIRUS TYPE 1 (BoHV-1) QUADRUPLE GENE DELETED MUTANT
[patent_app_type] => utility
[patent_app_number] => 18/268553
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18268553
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/268553 | BOVINE HERPESVIRUS TYPE 1 (BoHV-1) QUADRUPLE GENE DELETED MUTANT | Dec 20, 2021 | Pending |
Array
(
[id] => 19479891
[patent_doc_number] => 20240327933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => CORONAVIRUS RAPID DIAGNOSTICS
[patent_app_type] => utility
[patent_app_number] => 18/268156
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18268156
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/268156 | CORONAVIRUS RAPID DIAGNOSTICS | Dec 14, 2021 | Pending |
Array
(
[id] => 17704939
[patent_doc_number] => 20220204945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => AAV PRODUCTION USING SUSPENSION ADAPTED CELLS
[patent_app_type] => utility
[patent_app_number] => 17/544418
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17544418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/544418 | AAV PRODUCTION USING SUSPENSION ADAPTED CELLS | Dec 6, 2021 | Abandoned |
Array
(
[id] => 19361114
[patent_doc_number] => 20240263148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => Method for the Production of AAV
[patent_app_type] => utility
[patent_app_number] => 18/005027
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005027
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005027 | Method for the Production of AAV | Nov 22, 2021 | Pending |
Array
(
[id] => 17640667
[patent_doc_number] => 20220168405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => TREATMENT OF PRURITUS IN HORSES
[patent_app_type] => utility
[patent_app_number] => 17/530103
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17530103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/530103 | TREATMENT OF PRURITUS IN HORSES | Nov 17, 2021 | Abandoned |
Array
(
[id] => 18863313
[patent_doc_number] => 20230417749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => POLYNUCLEOTIDE NANOSTRUCTURES FOR DETECTING VIRAL INFECTIONS AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/037433
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037433
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/037433 | POLYNUCLEOTIDE NANOSTRUCTURES FOR DETECTING VIRAL INFECTIONS AND OTHER DISEASES | Nov 17, 2021 | Pending |
Array
(
[id] => 20510107
[patent_doc_number] => 20260034206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-05
[patent_title] => VACCINE PLATFORM
[patent_app_type] => utility
[patent_app_number] => 18/033648
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033648
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033648 | VACCINE PLATFORM | Oct 25, 2021 | Pending |
Array
(
[id] => 19339467
[patent_doc_number] => 12049648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Adeno-associated virus compositions for targeted gene therapy
[patent_app_type] => utility
[patent_app_number] => 17/503972
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 211
[patent_figures_cnt] => 50
[patent_no_of_words] => 57468
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503972 | Adeno-associated virus compositions for targeted gene therapy | Oct 17, 2021 | Issued |
Array
(
[id] => 19339467
[patent_doc_number] => 12049648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Adeno-associated virus compositions for targeted gene therapy
[patent_app_type] => utility
[patent_app_number] => 17/503972
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 211
[patent_figures_cnt] => 50
[patent_no_of_words] => 57468
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503972 | Adeno-associated virus compositions for targeted gene therapy | Oct 17, 2021 | Issued |
Array
(
[id] => 17713685
[patent_doc_number] => 11377669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
[patent_app_type] => utility
[patent_app_number] => 17/499555
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 112
[patent_figures_cnt] => 112
[patent_no_of_words] => 30209
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499555
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499555 | Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby | Oct 11, 2021 | Issued |
Array
(
[id] => 17720781
[patent_doc_number] => 20220213501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => METHOD OF DETECTING AND/OR IDENTIFYING ADENO-ASSOCIATED VIRUS (AAV) SEQUENCES AND ISOLATING NOVEL SEQUENCES IDENTIFIED THEREBY
[patent_app_type] => utility
[patent_app_number] => 17/499531
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499531
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499531 | Method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby | Oct 11, 2021 | Issued |